Aster DM Healthcare Share Price Aster DM Health.

123.15

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

123.15

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 08-Aug-2019 28-May-2019 - -
With reference to the captioned subject, we wish to inform you that: Pursuant to the recommendations of the Audit and Risk Management Committee, M/s BSR & Associates LLP shall be appointed as the Statutory Auditors of the Company at the ensuing AGM to hold office till the conclusion of the 12th AGM, subject to approval of the shareholders The 11th Annual General Meeting (AGM) of the Company shall be held on 8th August 2019. The cut-off date for ascertaining the list of t he shareholders to whom the Notice of t he 11th AGM shall be sent has been fixed as 5th July 2019 and for determining the eligibility of shareholders to vote on t he resolutions proposed at the 11th Annual General Meeting of the Company has been fixed as 1st August 2019. Aster DM Healthcare Ltd has informed BSE about Outcome of Board Meeting held on July 28, 2019. (As Per BSE Announcement Dated on 01.07.2019) Notice of 11th Annual General Meeting to be held on 8th August 2019 at 10.00 am at the registered office of the Company at the Knowledge Hub, Annexe Building, IX/475L, Aster Medcity, Kuttisahib Road, Near Kothad Bridge, South Chittoor P.O Cheranalloor, Kochi-682027, Kerala, India (As Per BSE Announcement Dated On 15/07/2019) In furtherance to our letter dated 15th July 2019 regarding the notice of the 11th Annual General Meeting, for providing better clarity to the shareholders, it is proposed to modify the resolution set out at Agenda Item No. 9 of the Notice of the AGM along with the explanatory statement. Agenda Item No. 9 proposes to seek approval of the shareholders for contribution to Bona fide Charitable Funds/Trusts. Further it is proposed to make additional disclosure in the explanatory statement pertaining to the Agenda Item No.6 of the Notice of the AGM seeking approval of the shareholders for re-appointment of Dr. Azad Moopen as Managing Director of the Company for a period of five years. The above modification/additional disclosure in the Notice of AGM is proposed to be effected by way of an Addendum dated August 1, 2019 Accordingly, Addendum dated 1st August 2019 to the Notice of the 11th AGM providing the aforementioned disclosure is enclosed for your information. (As Per BSE Announcement Dated 01.08.2019) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 11th Annual General Meeting (AGM) of the Company was held on 8th August 2019 at Knowledge Hub, Aster Medcity, Kochi, Kerala, India - 682 027 and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of AGM in compliance with the provisions of aforesaid regulations. We request you to kindly take on record the above information. (As Per BSE Announcement Dated On 08/08/2019) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 11th Annual General Meeting (AGM) of the Company was held on August 8, 2019 at Knowledge Hub, Aster Medcity, Kochi, Kerala, India - 682 027 and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the following; 1.Submission of voting results in compliance with the provisions of regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure- I 2.Report of Scrutinizer dated August 9, 2019 in compliance with the provisions of section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration), Rules 2014 as Annexure -II We request you to kindly take on record the above information. (As Per BSE Announcement Dated 09.08.2019) Aster DM Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated On 10/08/2019) Pursuant to special resolution passed by the shareholders of Aster DM Healthcare Limited (the Company) at the Annual General Meeting held on August 08, 2019 for re-appointment of Dr. Azad Moopen as Managing Director of the Company for a period of 5 years subject to approval of Central Government, please be informed that the Central Government has granted approval for the re- appointment of Dr. Azad Moopen as Managing Director of the Company with effect from December 01, 2019 for a period of 3 years, 4 months and 13 days i.e upto April 14, 2023 on which date Dr. Azad Moopen shall be attaining the age of 70 years. Further, Dr. Azad Moopen has given an undertaking to the Company as prescribed in the Central Government order on March 10, 2020 which has been filed with the Registrar of Companies, Kerala on the same day. A copy of the Central Government order has been enclosed for your reference. We request you to kindly take the above information on record (As Per BSE Announcement dated on 11.03.2020)